| Dr Muhammad Khyzar Hayat Syed, MD | |
|
6720 Bertner Ave, Houston, TX 77030-2604 | |
| (713) 798-1000 | |
| Not Available |
| Full Name | Dr Muhammad Khyzar Hayat Syed |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 17 Years |
| Location | 6720 Bertner Ave, Houston, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093091084 | NPI | - | NPPES |
| 4884406 | Other | NC | AETNA |
| 109309184 | Medicaid | NC | |
| 3647331 | Other | NC | UNITED HEALTHCARE |
| 1093091084 | Other | NC | VIRGINIA MEDICAID |
| 1093091084 | Other | NC | PARTNERS |
| 1796X | Other | NC | BCBS |
| 268260 | Other | NC | MEDCOST |
| 1093091084 | Other | NC | TRICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | S5648 (Texas) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | S5648 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Luke's Sugar Land Hospital | Sugar land, TX | Hospital |
| Chi St Luke's Health Baylor College Of Medicine Me | Houston, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baylor College Of Medicine | 8022243971 | 917 |
News Archive
The fixed-dose combination of sacubitril and valsartan (trade name: Entresto) has been approved since November 2015 for adults with symptomatic chronic heart failure with reduced pump function (ejection fraction). The German Institute for Quality and Efficiency in Health Care (IQWiG) now examined in an early benefit assessment whether this drug combination offers an added benefit for patients in comparison with the appropriate comparator therapy.
Verisk Health, Inc., announced today that Atrius Health has selected Sightlines Medical Intelligence and DxCG Risk Solutions to identify, manage, and predict healthcare risk across its commercial, Medicaid, and Medicare populations.
A 65-year-old woman with Parkinson's disease became the first patient in the United States to receive a new device for deep brain stimulation (DBS) therapy.
Making sure you get right back on your weight loss plan after a big holiday meal is what will help you maintain your weight this holiday season.
› Verified 9 days ago
| Entity Name | Baylor College Of Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053352914 PECOS PAC ID: 8224941265 Enrollment ID: O20031106000562 |
News Archive
The fixed-dose combination of sacubitril and valsartan (trade name: Entresto) has been approved since November 2015 for adults with symptomatic chronic heart failure with reduced pump function (ejection fraction). The German Institute for Quality and Efficiency in Health Care (IQWiG) now examined in an early benefit assessment whether this drug combination offers an added benefit for patients in comparison with the appropriate comparator therapy.
Verisk Health, Inc., announced today that Atrius Health has selected Sightlines Medical Intelligence and DxCG Risk Solutions to identify, manage, and predict healthcare risk across its commercial, Medicaid, and Medicare populations.
A 65-year-old woman with Parkinson's disease became the first patient in the United States to receive a new device for deep brain stimulation (DBS) therapy.
Making sure you get right back on your weight loss plan after a big holiday meal is what will help you maintain your weight this holiday season.
› Verified 9 days ago
| Entity Name | Baylor College Of Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881026664 PECOS PAC ID: 8022243971 Enrollment ID: O20131030000972 |
News Archive
The fixed-dose combination of sacubitril and valsartan (trade name: Entresto) has been approved since November 2015 for adults with symptomatic chronic heart failure with reduced pump function (ejection fraction). The German Institute for Quality and Efficiency in Health Care (IQWiG) now examined in an early benefit assessment whether this drug combination offers an added benefit for patients in comparison with the appropriate comparator therapy.
Verisk Health, Inc., announced today that Atrius Health has selected Sightlines Medical Intelligence and DxCG Risk Solutions to identify, manage, and predict healthcare risk across its commercial, Medicaid, and Medicare populations.
A 65-year-old woman with Parkinson's disease became the first patient in the United States to receive a new device for deep brain stimulation (DBS) therapy.
Making sure you get right back on your weight loss plan after a big holiday meal is what will help you maintain your weight this holiday season.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Muhammad Khyzar Hayat Syed, MD 6720 Bertner Ave, Houston, TX 77030-2604 Ph: (713) 798-1000 | Dr Muhammad Khyzar Hayat Syed, MD 6720 Bertner Ave, Houston, TX 77030-2604 Ph: (713) 798-1000 |
News Archive
The fixed-dose combination of sacubitril and valsartan (trade name: Entresto) has been approved since November 2015 for adults with symptomatic chronic heart failure with reduced pump function (ejection fraction). The German Institute for Quality and Efficiency in Health Care (IQWiG) now examined in an early benefit assessment whether this drug combination offers an added benefit for patients in comparison with the appropriate comparator therapy.
Verisk Health, Inc., announced today that Atrius Health has selected Sightlines Medical Intelligence and DxCG Risk Solutions to identify, manage, and predict healthcare risk across its commercial, Medicaid, and Medicare populations.
A 65-year-old woman with Parkinson's disease became the first patient in the United States to receive a new device for deep brain stimulation (DBS) therapy.
Making sure you get right back on your weight loss plan after a big holiday meal is what will help you maintain your weight this holiday season.
› Verified 9 days ago
Dr. Michaela Elizabeth Ginn, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 13214 Indian Creek Road, Houston, TX 77079 Phone: 713-591-3555 Fax: 661-321-3286 | |
Ameena Bagree Malhotra, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1515 Holcombe Blvd, 77030-4009, Houston, TX 77030 Phone: 713-792-6161 | |
Svetang Vijay Desai, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 444 Fm 1959 Rd, Suite A, Houston, TX 77034 Phone: 281-481-9400 | |
Dr. Stalin R Subramanian, M.D Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 7200 Cambridge St Fl 8, Houston, TX 77030 Phone: 713-798-0950 | |
Robin Boliver-campbell, M.D. Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 7141 Southwest Fwy, Houston, TX 77074 Phone: 713-771-7921 Fax: 713-264-8659 | |
Henna Mukhtar Malik, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 13215 Dotson Rd Ste 300, Houston, TX 77070 Phone: 281-894-8822 | |
Zaven Sargsyan, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2002 Holcombe Blvd, Department Of Medicine, Houston, TX 77030 Phone: 713-791-1414 |